| Autor: |
Chaykin, Louis, Bhargava, Anuj, de la Rosa, Raymond, Wysham, Carol H., Troelsen, Lone Nørgård, Østoft, Signe H., Philis-Tsimikas, Athena |
| Předmět: |
|
| Zdroj: |
Clinical Diabetes; Winter2019, Vol. 37 Issue 1, p73-81, 9p |
| Abstrakt: |
Hispanic patients with type 2 diabetes have poorer glycemic control and are at higher risk of severe diabetes complications and mortality than non-Hispanic white patients. This post hoc analysis investigated the safety and efficacy of insulin degludec versus insulin glargine 100 units/mL (glargine U100) in the Hispanic patient subpopulation from the SWITCH 2 trial. In Hispanic patients, hypoglycemia was consistently lower and nocturnal hypoglycemia was significantly lower with degludec versus glargine U100 at similar levels of glycemic control. Overall, results in Hispanic patients in SWITCH 2 were consistent with those in non-Hispanic patients. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
